Home >  Registry
     
 
 Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Neoplasms

  • A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.
    Recruiting


  • A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.
    Recruiting


  • A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.
    Recruiting


  • A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors.
    Recruiting


  • A Study of R7112 in Patients With Advanced Solid Tumors.
    Recruiting


  • A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
    Recruiting


  • A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.
    Recruiting


  • A Study of R547 in Patients With Advanced Solid Tumors.
    No longer recruiting


  • A Study of Weekly Tubulin Polymerisation Inhibitor (Tub-2) in Patients With Advanced Solid Tumors.
    Completed


  • A Study of 3 Weekly Tubulin Polymerisation Inhibitor (Tub-2) in Patients With Advanced Solid Tumors.
    Completed


    		•

    © 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement